Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial.
Fragoso-Saavedra S, Núñez I, Audelo-Cruz BM, Arias-Martínez S, Manzur-Sandoval D, Quintero-Villegas A, Benjamín García-González H, Carbajal-Morelos SL, PoncedeLeón-Rosales S, Gotés-Palazuelos J, Maza-Larrea JA, Rosales-de la Rosa JJ, Diaz-Rivera D, Luna-García E, Piten-Isidro E, Del Río-Estrada PM, Fragoso-Saavedra M, Caro-Vega Y, Batina I, Islas-Weinstein L, Iruegas-Nunez DA, Calva JJ, Belaunzarán-Zamudio PF, Sierra-Madero J, Crispín JC, Valdés-Ferrer SI. Fragoso-Saavedra S, et al. Mol Med. 2022 Nov 8;28(1):131. doi: 10.1186/s10020-022-00553-x. Mol Med. 2022. PMID: 36348276 Free PMC article. Clinical Trial.
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
Fragoso-Saavedra S, Iruegas-Nunez DA, Quintero-Villegas A, García-González HB, Nuñez I, Carbajal-Morelos SL, Audelo-Cruz BM, Arias-Martínez S, Caro-Vega Y, Calva JJ, Luqueño-Martínez V, González-Duarte A, Crabtree-Ramírez B, Crispín JC, Sierra-Madero J, Belaunzarán-Zamudio PF, Valdés-Ferrer SI. Fragoso-Saavedra S, et al. BMC Infect Dis. 2020 Oct 16;20(1):765. doi: 10.1186/s12879-020-05485-7. BMC Infect Dis. 2020. PMID: 33066761 Free PMC article.
Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients.
Núñez I, Priego-Ranero ÁA, García-González HB, Jiménez-Franco B, Bonilla-Hernández R, Domínguez-Cherit G, Merayo-Chalico J, Crispín JC, Barrera-Vargas A, Valdés-Ferrer SI. Núñez I, et al. Clin Immunol. 2021 Apr;225:108682. doi: 10.1016/j.clim.2021.108682. Epub 2021 Feb 4. Clin Immunol. 2021. PMID: 33549831 Free PMC article.
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
García-Grimshaw M, Ceballos-Liceaga SE, Hernández-Vanegas LE, Núñez I, Hernández-Valdivia N, Carrillo-García DA, Michel-Chávez A, Galnares-Olalde JA, Carbajal-Sandoval G, Del Mar Saniger-Alba M, Carrillo-Mezo RA, Fragoso-Saavedra S, Espino-Ojeda A, Blaisdell-Vidal C, Mosqueda-Gómez JL, Sierra-Madero J, Pérez-Padilla R, Alomía-Zegarra JL, López-Gatell H, Díaz-Ortega JL, Reyes-Terán G, Arauz A, Valdés-Ferrer SI. García-Grimshaw M, et al. Clin Immunol. 2021 Aug;229:108786. doi: 10.1016/j.clim.2021.108786. Epub 2021 Jun 18. Clin Immunol. 2021. PMID: 34147649 Free PMC article.
Delirium and Associated Factors in a Cohort of Hospitalized Patients With Coronavirus Disease 2019.
García-Grimshaw M, Chiquete E, Jiménez-Ruiz A, Vidal-Mayo JJ, Grajeda-González SL, Vargas-Martínez MLÁ, Toapanta-Yanchapaxi LN, Valdés-Ferrer SI, Chávez-Martínez OA, Marché-Fernández OA, Jiménez-Ávila AI, Cantú-Brito C, Flores-Silva FD. García-Grimshaw M, et al. J Acad Consult Liaison Psychiatry. 2022 Jan-Feb;63(1):3-13. doi: 10.1016/j.jaclp.2021.06.008. Epub 2021 Jul 6. J Acad Consult Liaison Psychiatry. 2022. PMID: 34242847 Free PMC article.
Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis.
García-Grimshaw M, Chirino-Pérez A, Flores-Silva FD, Valdés-Ferrer SI, Vargas-Martínez MLÁ, Jiménez-Ávila AI, Chávez-Martínez OA, Ramos-Galicia EM, Marché-Fernández OA, Ramírez-Carrillo MF, Grajeda-González SL, Ramírez-Jiménez ME, Chávez-Manzanera EA, Tusié-Luna MT, Ochoa-Guzmán A, Cantú-Brito C, Fernandez-Ruiz J, Chiquete E. García-Grimshaw M, et al. Neurol Sci. 2022 Apr;43(4):2217-2229. doi: 10.1007/s10072-021-05798-8. Epub 2022 Jan 13. Neurol Sci. 2022. PMID: 35022935 Free PMC article.
72 results